EUCTR2006-001866-18-Outside-EU/EEA进行中（未招募）1 期
A Randomized, Double-Blind, Crossover Comparison of Atomoxetine and Placebo in Child Outpatients With Attention-Deficit/Hyperactivity Disorder, Reading Disorder, or Comorbid Attention-Deficit/Hyperactivity Disorder and Reading Disorder.
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1) Clinical diagnosis with Attention Deficit Hyperactivity Disorder and/or Reading Disorder.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 121
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1) Patients with Conduct Disorder
- •2) Patients who have a history of Bipolar I or II Disorder, psychosis, or Pervasive Development Disorder.
- •3) Patients who have a current diagnosis of Vocal Tic Disorder, Obsessive Compulsive Disorder, Major Depressive Disorder, Post Traumatic Stress Disorder, Anxiety Disorder, and certain other learning disorders.
研究者
相似试验
已完成
不适用
A randomised, double-blind, crossover comparison of the efficacy and safety of study drug 017 and placebo in patients with neuropathic pain due to diabetic neuropathy (DN) or post-herpetic neuralgia (PHN)ISRCTN33347454Purdue Pharma Canada70
已完成
不适用
A randomised, crossover, double blind comparison of the analgesic effect and patient tolerability of nabilone and dihydrocodeine in chronic neuropathic paiISRCTN15330757Cambridge Laboratories Ltd (UK)100
已完成
不适用
A Randomized, Double-Blind, Crossover, Comparative Pharmacokinetic Trial of Deulevodopa (TEV-50939) and Levodopa, both Administered with Carbidopa in Healthy Subjectsmovement disorder10028037NL-OMON42683Teva Pharmaceuticals International GmbH16
已完成
不适用
A clinical Study to Assess the safety and Efficacy of COCOZEN as a sports performance supplement in Healthy athletesCTRI/2018/03/012551Akay Flavours and Aromatics Private Limited48
进行中（未招募）
2 期
A Trial of MitoQ for the Treatment of People with Parkinson's DiseaseParkinson's diseaseNeurological - DementiasACTRN12606000218594Antipodean Pharmaceuticals, Inc120